NEW YORK (GenomeWeb News) – VisionGate will use semiconductor developer MathStar’s technology to develop a medical imaging solution for cellular characterization that would be used to scan cells in patients at risk of cancer, MathStar said today.
 
Under the agreement, VisionGate will use MathStar’s Arrix FPOA chip as the processing engine for its Cell-CT platform, which is entering investigational clinical trials, MathStar said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.